NDC 17238-900-99 - BioGlo
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17238-900
- Requested NDC
- 17238-900-99
- Package NDCs from labels
- 17238-900-99, 17238-900-11, 17238-900-30
- Manufacturer
- HUB Pharmaceuticals, Inc. | OMNI LENS PRIVATE LIMITED | Madhu Instruments Pvt.Ltd.
- Effective date
- 2024-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BIO GLO (fluorescein sodium) strip | HUB Pharmaceuticals, Inc. | OMNI LENS PRIVATE LIMITED | Madhu Instruments Pvt.Ltd. | 2024-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17238-900-11 | 2026-01-29 | C162847 | 48780-1 | 49896155-afd0-586f-e063-e6dba90add90 | BIO GLO (fluorescein sodium) strip |
| 17238-900-30 | 2026-01-29 | C162847 | 48780-1 | 49896155-afd0-586f-e063-e6dba90add90 | BIO GLO (fluorescein sodium) strip |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17238-900-11 | BioGlo | 100 in 1 BOX | STRIP | 100 | 9 | |
| 17238-900-30 | BioGlo | 300 in 1 BOX | STRIP | 300 | 9 | |
| 17238-900-99 | BioGlo | 1 mg in 1 PACKET | STRIP | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17238-900-11 | EA - Each | 17238-900 | c6b6698b-88c1-4277-96a0-8c949c7b8b15 | 1 | 2012-07-24 |
| 17238-900-30 | EA - Each | 17238-900 | 33463b16-cbce-4a9a-a98b-0732164f8ffb | 1 | 2012-07-24 |
| 17238-900-99 | EA - Each | 17238-900 | 31a423b7-192d-4b1a-887c-6379ee2b6571 | 1 | 2023-10-16 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FLUORESCEIN SODIUM | ACTIVE INGREDIENT | 93X55PE38X | BIOGLO (FLUORESCEIN SODIUM) STRIP [HUB PHARMACEUTICALS, INC.] | 1 | |
| FLUORESCEIN | ACTIVE MOIETY | TPY09G7XIR | BIOGLO (FLUORESCEIN SODIUM) STRIP [HUB PHARMACEUTICALS, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FLUORESCITE | FLUORESCEIN SODIUM | Alcon, Inc. | ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9 | 2026-06-29 | Warnings, Adverse reactions | 93X55PE38X |
| Fluorescein | FLUORESCEIN | Zydus Lifesciences Limited | 5c88e2a2-b05c-46f2-9874-c935e4b96a6e | 2026-06-02 | 93X55PE38X | |
| Fluorescein | FLUORESCEIN | Zydus Pharmaceuticals USA Inc. | 19aea137-3f47-4b69-9884-3bff5f79b04a | 2026-06-02 | Warnings, Adverse reactions | 93X55PE38X |
| Fluorescein | FLUORESCEIN | BPI Labs LLC | 770582e3-c99b-4a02-868c-29309013717e | 2026-05-01 | Warnings, Adverse reactions | 93X55PE38X |
| AK-FLUOR | FLUORESCEIN | Long Grove Pharmaceuticals, LLC | 73511e79-c050-4dc0-aa2f-a79ed320b5b0 | 2026-02-26 | Warnings, Adverse reactions | 93X55PE38X |
| C20H10Na2O5 Fluorescein Sodium Ophthalmic Strips | FLUORESCEIN SODIUM | Vistamerica USA | 292abb69-84ad-4f61-e063-6394a90a1447 | 2025-06-01 | 93X55PE38X | |
| Fluorescein Sodium and Benoxinate Hydrochloride | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | Bausch & Lomb Americas Inc. | f935b5f8-dc6e-4425-a668-968ee3855f51 | 2025-05-12 | Warnings, Adverse reactions | 93X55PE38X |
| Fluorescein Sodium and Benoxinate Hydrochloride | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | Bausch & Lomb Incorporated | 1797c5ef-66c4-4cf8-b62d-b484242be2ee | 2025-05-12 | Warnings, Adverse reactions | 93X55PE38X |
| 0e86525e-501b-e995-e063-6294a90a4d9c | f72b68c7-a52f-40df-a47d-8e2d8174091d | 2024-01-01 | 0e86525e-501b-e995-e063-6294a90a4d9c f72b68c7-a52f-40df-a47d-8e2d8174091d | |||
| Fluorescein Sodium and Proparacaine Hydrochloride | FLUORESCEIN SODIUM AND PROPARACAINE HYDROCHLORIDE | Altaire Pharmaceuticals Inc. | dae037ad-dcb8-42e6-8996-e575922d7631 | 2022-10-28 | Warnings, Adverse reactions | 93X55PE38X |
| FLUORESCEIN | FLUORESCEIN | HF Acquisition Co LLC, DBA HealthFirst | c1ffe119-7fba-940f-e053-2a95a90a7a17 | 2021-08-08 | Warnings, Adverse reactions | 93X55PE38X |
| Dry Eye Test | FLUORESCEIN SODIUM | Nomax Inc. | 04866053-f973-471e-b3bc-241fb76303a2 | 2019-12-23 | 93X55PE38X | |
| GloStrips | FLUORESCEIN SODIUM | Nomax Inc. | d06a4432-c76c-4e2a-abec-6bc5b4e82d51 | 2019-12-23 | 93X55PE38X | |
| GloStrips | FLUORESCEIN SODIUM | Nomax Inc. | f5dbf66b-068d-4408-989b-4f29b3c48738 | 2019-12-23 | 93X55PE38X | |
| ALTAFLUOR | FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE | Altaire Pharmaceuticals Inc. | 54017304-e680-4129-b52a-69cb9810af76 | 2017-12-06 | Warnings, Adverse reactions | 93X55PE38X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.